DocGo Inc. (DCGO) vs Elicio Therapeutics, Inc. (ELTX)
A side-by-side comparison of DocGo Inc. and Elicio Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DCGO
DocGo Inc.
$0.36HealthcareDelayed quote: Oct 6, 2026, 3:24 PM EDT
ELTX
Elicio Therapeutics, Inc.
$1.88HealthcareDelayed quote: Oct 6, 2026, 3:25 PM EDT
Total return — DCGO vs ELTX
growth of $100 · dividends reinvested · last 3yDCGO -93.5% (-59.9%/yr)ELTX -67.4% (-31.2%/yr)ELTX compounded faster over this window
Log scale — wide-divergence pair
DCGO ELTX
DCGO vs ELTX: by the numbers
- •ELTX is the larger company ($36M vs $35M market cap).
- •Both run net losses; ELTX's is the smaller (0.00% vs -65.29% net margin).
Metrics side by side
Valuation
| Metric | DCGO | ELTX |
|---|---|---|
| P/S ratio | 0.12 | N/A |
| P/B ratio | 0.30 | 4.50 |
Profitability
| Metric | DCGO | ELTX |
|---|---|---|
| Gross margin | 30.12% | 0.00% |
| Operating margin | -27.67% | 0.00% |
| Net margin | -65.29% | 0.00% |
| ROE | -161.63% | -476.77% |
| ROIC | -89.44% | -171.36% |
Growth (annualized)
| Metric | DCGO | ELTX |
|---|---|---|
| Revenue CAGR (5Y) | 11.63% | N/A |
| Total return CAGR (5Y) | -48.40% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.